source
- WuXi Bio sells majority stake in chromatography resin maker Bestchrom; Cabaletta adds new CDMO partnerWuXi Bio announced it will divest its 51.1% equity interest in Bestchrom, a Shanghai-based supplier of chromatography resins. The sale will transfer control to an unnamed third party, marking WuXi…
- Epic expands AI tools for clinicians and patients, intensifying competition for health-tech startupsEpic highlighted its growing portfolio of artificial‑intelligence applications for both clinicians and patients at its annual Users Group Meeting in Verona, Wisconsin. The presentation showcased ne…